Mezzion Pharma
MEZZION PHARMA CO LTD Logo
About MEZZION PHARMA CO LTD
Mezzion Pharma Co Ltd develops and licenses pharmaceutical products internationally, with a focus on treatments for benign prostatic hyperplasia, erectile dysfunction, and conditions related to Fontan circulation. The company is known for conducting large-scale clinical trials, including the FUEL-2 phase-3 trial of udenafil for adolescents with Fontan circulation.
Year founded
2002
Number of employees
0-100
Sector
Health Care
Industry Group
Pharmaceuticals, Biotechnology & Life Sciences
Industry
Pharmaceuticals
Report inaccurate data
Request an update to help us keep the brand up-to-date.
